The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-β-d-arabinofuranosylcytosine

Treatment of intravenously implanted lew

Treatment of intravenously implanted lewis lung carcinoma with liposome-encapsulated cytosine arabinoside and non-specific immunotherapy

✍ Kanaiyalal R. Patel; John D. Baldeschwieler 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 544 KB

## Abstract Liposomes have been used as biological carriers of anti‐tumor drugs, and their potential use has been tested using various mouse tumors. In this study, we describe a potential role of liposome‐encapsulated 1‐β‐D‐arabinofuranosyl‐cytosine (Ara‐C) with a mouse solid lung tumor model. Non‐